COPENHAGEN, Denmark, May 29 /PRNewswire/ -- - Updates on Phase III Studies With Ofatumumab, Zalutumumab and Zanolimumab.

Genmab A/S (OMX: GEN) reports today that the last patient to be included in the planned interim analysis (N=132 patients) in the pivotal Phase III clinical trial of ofatumumab (HuMax-CD20(R)) in refractory chronic lymphocytic leukemia (CLL) has now received the last scheduled treatment.

In order to complete the database and allow for assessment of the responses by an independent committee, the final data will now be collected and analysed with the results expected in early August 2008. Pending a positive outcome, a Biologics License application in this indication is expected to be filed before the end of 2008.

SAN FRANCISCO, May 29 /PRNewswire/ --

- Delivers the most up to date PCI compliance tool to merchants and service providers

AMSTERDAM, Netherlands, May 29 /PRNewswire/ --

- PlayV Ltd to distribute titles in the UK

Today publisher Playlogic Entertainment Inc. (OTC Bulletin Board: PLGC) and publisher/distributor Virgin PLAY announced their joint venture PlayV Ltd.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071119/PLAYLOGICLOGO )

PlayV Ltd, a sales, marketing and distribution business, will bring PC, console and handheld products from both parties to the UK market and also offer flexible pro-active PR, marketing and sales solutions to additional development and publishing partners looking to penetrate the UK retail market with their products.

GHENT, Belgium, May 29 /PRNewswire/ --

- Localisation and Quality Key Criteria for New Applications

Netlog, Europe's leading social networking platform, today announced at the Google I/O conference in San Francisco that it has joined Google's OpenSocial initiative. Starting today, social networking applications developed using the OpenSocial standards can be made available to Netlog's 35 million users across Europe.

DOYLESTOWN, Pennsylvania, May 29 /PRNewswire/ --

- Novel self-expanding intracoronary prosthesis successfully placed in three patients with coronary artery disease

Three patients with established cardiac ischemia recently became the first recipients of the vProtect Luminal Shield, a self-expanding intracoronary prosthesis designed to limit arterial injury that typically occurs when stents are deployed. The Shield also provides robust biocompatible support for the vessel to ensure that the target coronary artery will remain patent after placement.

PARIS, May 29 /PRNewswire/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced the availability of its 2007 Corporate Social Responsibility Report. The report underlines Alcatel-Lucent's commitment to corporate social responsibility and presents the main achievements and initiatives undertaken by the company in 2007.

Patricia Russo, CEO of Alcatel-Lucent stated: "Corporate social responsibility has become a business imperative. For Alcatel-Lucent, CSR is not merely a set of policies: it is a key component of the company's business strategy. Going forward we will continue to strengthen CSR within our company to meet the expectations of our shareholders, our customers, our employees, and the communities in which we conduct business."

AMSTERDAM, May 29 /PRNewswire/ --

- Dr. Mielke Continues his Collaboration With Kiadis Pharma on ATIR(TM)

Biopharmaceutical company Kiadis Pharma announces today the clinical development collaboration for its lead product ATIR(TM) with Dr. Stephan Mielke and Professor Dr. Hermann Einsele from the Allogeneic Stem Cell Transplant Center, Division of Hematology and Oncology, Department of Internal Medicine II at the Julius-Maximilians University of Würzburg, Germany. Principal investigator of this collaboration will be Dr. Mielke.

FARNBOROUGH, England, May 29 /PRNewswire/ --

- Infor Survey Also Reveals Supply Chain Visibility and Shrinking Margins as Biggest Pressure Points in 2008

Infor today released the findings of its latest research, which reveal that supply chain professionals are calling upon the UK Government to help reduce the industry's carbon footprint. Two thirds (67 per cent) of supply chain professionals surveyed, believe their environmental initiatives should be subsidised by the state.

LONDON, May 29 /PRNewswire/ -- "Cheap fuel" and "cheap petrol" are both new entries in the top twenty most searched for financial terms on the internet this month according to leading search engine, Ask.com, as householders and motorists suffer the consequences of the spiralling cost of oil.

Results to the searches are pointing consumers to specialist sites giving advice on where to get the best deals for both domestic energy supplies at home and petrol on the garage forecourt.

LONDON, May 29 /PRNewswire/ --

- Examining Planning and Budgeting in Europe

At the 2008 Tagetik User Conference, Business Application Research Center (BARC) released the preliminary results of its latest study titled "Planning and Budgeting in Europe - Status quo and opportunities for Performance Management". BARC researched different planning requirements and approaches in 500 European companies.

"We focused on planning and budgeting due to the complex and changing nature of these processes," explains Dr. Carsten Bange, CEO at BARC. "As organisations grow and more stakeholders become involved, these processes quickly become even more challenging."